These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 608521)

  • 1. The potential of lymphokines in the treatment of cancer.
    Hamblin AS; Wolstencroft RA; Dumonde DC; Hollander FD; Schuurs AH; Backhouse BM; O'Connell D; Paradinas F
    Dev Biol Stand; 1977 Apr 13-15; 38():335-41. PubMed ID: 608521
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphokine preparations: a new approach to cancer immunotherapy.
    Papermaster BW; Kaltenbach ML
    Mo Med; 1978 Dec; 75(12):607-9, 612. PubMed ID: 723839
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukoregulin.
    Evans CH
    Prog Clin Biol Res; 1989; 288():259-70. PubMed ID: 2654952
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphokines and cytokines.
    Wagstaff J; Melief KJ
    Cancer Chemother Biol Response Modif; 1987; 9():432-53. PubMed ID: 2484327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lymphokines].
    Aoki R
    Kekkaku; 1975 Dec; 50(11):480-2. PubMed ID: 1221152
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer therapy by biological response modifiers.
    Herberman RB
    Arzneimittelforschung; 1987 Feb; 37(2A):246-50. PubMed ID: 2436633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction to TNF and related lymphokines.
    Gifford GE; Duckworth DH
    Biotherapy; 1991; 3(2):103-11. PubMed ID: 2054251
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lymphokines].
    Okuno K; Hamaoka T
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2053-64. PubMed ID: 6764096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of murine and human tumors in mice with lymphokines and interleukin-2-propagated lymphocytes.
    Kedar E; Chriqui-Zeira E; Kyriazis AP
    J Biol Response Mod; 1984 Oct; 3(5):517-26. PubMed ID: 6334139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphokines and cytokines.
    Wagstaff J; Melief K
    Cancer Chemother Biol Response Modif; 1988; 10():416-33. PubMed ID: 2484321
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphokines and cancer.
    Cavallo G
    G Batteriol Virol Immunol; 1990; 83(1-12):156-63. PubMed ID: 2133324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological Response Modifiers Programme and cancer chemotherapy.
    Oldham RK
    Int J Tissue React; 1982; 4(3):173-88. PubMed ID: 6183193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor-regressive potency of soluble factors released from tumor-immune cells].
    Sasaki J; Oh-hashi H; Morita M
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2557-62. PubMed ID: 6508316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lymphokine-containing sera on adenocarcinoma BW10232 and melanoma B16 in C57BL/6 mice.
    Moulton RG; Daniels JC
    J Natl Cancer Inst; 1980 Apr; 64(4):901-3. PubMed ID: 6154164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologicals and biological response modifiers: fourth modality of cancer treatment.
    Oldham RK
    Cancer Treat Rep; 1984 Jan; 68(1):221-32. PubMed ID: 6198081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I clinical trial of an MAF-containing lymphoblastoid cell line supernatant.
    Reynolds RD; McEntire JE; Rodes ND; Dunn PA; Walter J; Doyle MK; Anson NO; Garcia A; Oxenhandler RW; Khojasteh A
    J Biol Response Mod; 1986 Apr; 5(2):129-39. PubMed ID: 3525761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of lymphokine-activated killer cells in strain 2 guinea pigs and their use in the therapy of L2C, an acute B-cell leukemia.
    Gregg EO; Gregg IC; Green I
    Cancer Res; 1987 Feb; 47(3):723-9. PubMed ID: 3492265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular engineering of the antitumor immune response.
    Pardoll DM; Golumbek P; Levitsky H; Jaffee L
    Bone Marrow Transplant; 1992; 9 Suppl 1():182-6. PubMed ID: 1387016
    [No Abstract]   [Full Text] [Related]  

  • 19. Summary of contributed presentations: lymphokines and thymic factors.
    Cohen S
    Fed Proc; 1981 Jan; 40(1):54-5. PubMed ID: 7450064
    [No Abstract]   [Full Text] [Related]  

  • 20. Preclinical evaluation of the interrelationships between cancer chemotherapy and immunity.
    Mihich E
    Natl Cancer Inst Monogr; 1971 Dec; 34():90-102. PubMed ID: 4400958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.